دورية أكاديمية

Cytokine Levels in Neural Pain in Leprosy.

التفاصيل البيبلوغرافية
العنوان: Cytokine Levels in Neural Pain in Leprosy.
المؤلفون: Angst DBM; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Postgraduate Program in Neurology of Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil., Pinheiro RO; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil., Vieira JSDS; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil., Cobas RA; Endocrinology Discipline of the Faculty of Medical Sciences, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil., Hacker MAV; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil., Pitta IJR; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Postgraduate Program in Neurology of Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil., Giesel LM; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil., Sarno EN; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil., Jardim MR; Leprosy Laboratory, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Postgraduate Program in Neurology of Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.; Neurology Discipline of the Faculty of Medical Sciences, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
المصدر: Frontiers in immunology [Front Immunol] 2020 Jan 24; Vol. 11, pp. 23. Date of Electronic Publication: 2020 Jan 24 (Print Publication: 2020).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مواضيع طبية MeSH: Diabetic Neuropathies/*blood , Interleukin-1beta/*blood , Interleukin-6/*blood , Leprosy/*blood , Neuralgia/*blood , Neuritis/*blood, Aged ; Biomarkers/blood ; Brazil/epidemiology ; Cross-Sectional Studies ; Diabetic Neuropathies/diagnosis ; Diabetic Neuropathies/epidemiology ; Diagnosis, Differential ; Female ; Humans ; Leprosy/diagnosis ; Leprosy/epidemiology ; Male ; Middle Aged ; Neuralgia/diagnosis ; Neuralgia/epidemiology ; Neuritis/diagnosis ; Neuritis/epidemiology ; Retrospective Studies
مستخلص: Pain is a frequent symptom in leprosy patients. It may be predominantly nociceptive, as in neuritis, or neuropathic, due to injury or nerve dysfunction. The differential diagnosis of these two forms of pain is a challenge in clinical practice, especially because it is quite common for a patient to suffer from both types of pain. A better understanding of cytokine profile may serve as a tool in assessing patients and also help to comprehend pathophysiology of leprosy pain. Patients with leprosy and neural pain ( n = 22), neuropathic pain ( n = 18), neuritis (nociceptive pain) ( n = 4), or no pain ( n = 17), further to those with diabetic neuropathy and neuropathic pain ( n = 17) were recruited at Souza Araujo Out-Patient Unit (Fiocruz, Rio de Janeiro, RJ, Brazil). Serum levels of IL1β, IL-6, IL-10, IL-17, TNF, CCL-2/MCP-1, IFN-γ, CXCL-10/IP-10, and TGF-β were evaluated in the different Groups. Impairment in thermal or pain sensitivity was the most frequent clinical finding (95.5%) in leprosy neuropathy patients with and without pain, but less frequent in Diabetic Group (88.2%). Previous reactional episodes have occurred in patients in the leprosy and Pain Group ( p = 0.027) more often. Analysis of cytokine levels have demonstrated that the concentrations of IL-1β, TNF, TGF-β, and IL-17 in serum samples of patients having leprosy neuropathy in combination with neuropathic or nociceptive pain were higher when compared to the samples of leprosy neuropathy patients without pain. In addition, these cytokine levels were significantly augmented in leprosy patients with neuropathic pain in relation to those with neuropathic pain due to diabetes. IL-1β levels are an independent variable associated with both types of pain in patients with leprosy neuropathy. IL-6 concentration was increased in both groups with pain. Moreover, CCL-2/MCP-1 and CXCL-10/IP-10 levels were higher in patients with diabetic neuropathy over those with leprosy neuropathy. In brief, IL-1β is an independent variable related to neuropathic and nociceptive pain in patients with leprosy, and could be an important biomarker for patient follow-up. IL-6 was higher in both groups with pain (leprosy and diabetic patients), and could be a therapeutic target in pain control.
(Copyright © 2020 Angst, Pinheiro, Vieira, Cobas, Hacker, Pitta, Giesel, Sarno and Jardim.)
التعليقات: Comment in: Front Immunol. 2023 Dec 05;14:1272471. (PMID: 38116016)
References: Mem Inst Oswaldo Cruz. 2012 Mar;107(2):246-53. (PMID: 22415265)
J Zhejiang Univ Sci B. 2009 Aug;10(8):625-30. (PMID: 19650202)
J Neuroimmunol. 2010 Dec 15;229(1-2):26-50. (PMID: 20870295)
Eur J Neurol. 2018 Feb;25(2):348-355. (PMID: 29112785)
Ther Adv Musculoskelet Dis. 2018 Oct 07;10(10):195-199. (PMID: 30327685)
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73. (PMID: 5950347)
Neurosci Lett. 2008 Jun 6;437(3):188-93. (PMID: 18420346)
Mol Pain. 2007 Dec 12;3:38. (PMID: 18076762)
Curr Opin Neurol. 2017 Oct;30(5):490-499. (PMID: 28665811)
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3140-51. (PMID: 11124730)
Diagnostics (Basel). 2015 Mar 17;5(1):84-95. (PMID: 26854144)
Eur Spine J. 2013 Apr;22(4):714-20. (PMID: 23014739)
Neurology. 2014 Apr 15;82(15):1302-6. (PMID: 24634453)
Clin Immunol Immunopathol. 1992 Apr;63(1):23-7. (PMID: 1591878)
J Infect Dis. 1990 May;161(5):988-91. (PMID: 2324549)
Clin Dermatol. 2016 Jan-Feb;34(1):59-65. (PMID: 26773624)
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8032-7. (PMID: 19380717)
Lepr Rev. 2004 Sep;75(3):242-53. (PMID: 15508901)
Brain Behav Immun. 2007 Jul;21(5):522-7. (PMID: 17321718)
Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):134-8. (PMID: 15301591)
Eur J Neurol. 2010 Aug;17(8):1010-8. (PMID: 20298428)
PLoS Negl Trop Dis. 2011 Mar 08;5(3):e981. (PMID: 21408111)
Pathog Glob Health. 2014 Jun;108(4):186-90. (PMID: 24892791)
Brain Res. 2000 Oct 6;879(1-2):216-25. (PMID: 11011025)
Mol Cell Neurosci. 2008 Jan;37(1):170-7. (PMID: 17949992)
Am J Manag Care. 2006 Jun;12(9 Suppl):S256-62. (PMID: 16774457)
Lepr Rev. 2003 Dec;74(4):357-65. (PMID: 14750581)
Clin Neurol Neurosurg. 2015 Apr;131:5-10. (PMID: 25655301)
Pain Rep. 2018 Feb 23;3(2):e638. (PMID: 29756085)
J Neuroimmunol. 2001 Mar 1;114(1-2):48-56. (PMID: 11240015)
Cytokine. 2005 Jul 21;31(2):135-41. (PMID: 15935691)
Pain. 2012 Aug;153(8):1620-4. (PMID: 22727538)
J Comp Neurol. 1998 Jun 15;395(4):481-92. (PMID: 9619501)
J Neuropathol Exp Neurol. 2005 Oct;64(10):882-90. (PMID: 16215460)
Arch Phys Med Rehabil. 2007 Nov;88(11):1384-93. (PMID: 17964877)
Rev Soc Bras Med Trop. 2012 Jun;45(3):375-9. (PMID: 22760139)
Lepr Rev. 2007 Sep;78(3):223-30. (PMID: 18035773)
Arq Neuropsiquiatr. 2012 Jun;70(6):404-6. (PMID: 22699535)
Pain. 2013 Oct;154(10):2185-97. (PMID: 23831863)
Nat Med. 2008 Mar;14(3):331-6. (PMID: 18264108)
Rev Bras Anestesiol. 2009 May-Jun;59(3):297-303. (PMID: 19488542)
Rev Panam Salud Publica. 2018 Mar 16;42:e42. (PMID: 31093070)
Front Immunol. 2018 May 07;9:939. (PMID: 29867937)
J Neuropathol Exp Neurol. 2013 Apr;72(4):351-66. (PMID: 23481710)
Clin Neurophysiol. 2005 Jul;116(7):1571-80. (PMID: 15907395)
Cytokine. 2008 Feb;41(2):84-91. (PMID: 18039580)
J Biol Chem. 2016 Oct 7;291(41):21375-21387. (PMID: 27555322)
Infect Dis Poverty. 2016 Mar 07;5:18. (PMID: 26951147)
Pain. 2014 Jul;155(7):1293-302. (PMID: 24721689)
Am J Trop Med Hyg. 2018 Jun;98(6):1609-1613. (PMID: 29611495)
Lepr Rev. 2012 Jun;83(2):195-201. (PMID: 22997695)
Eur Spine J. 2006 Oct;15(10):1529-37. (PMID: 16474945)
Neurosci Lett. 2011 Apr 15;493(3):86-91. (PMID: 21316418)
Mol Med Rep. 2014 Oct;10(4):1954-8. (PMID: 25110203)
Neurology. 2001 Dec 26;57(12):2179-84. (PMID: 11756594)
J Neurol. 2003 Jul;250(7):806-9. (PMID: 12883921)
Clin Exp Immunol. 1991 Apr;84(1):103-8. (PMID: 2015700)
Mol Med Rep. 2017 Jan;15(1):89-96. (PMID: 27959414)
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7947-52. (PMID: 12808141)
Lepr Rev. 2011 Dec;82(4):371-82. (PMID: 22439277)
J Pain. 2012 Jan;13(1):10-20. (PMID: 22172450)
Biochim Biophys Acta. 2014 Nov;1843(11):2563-2582. (PMID: 24892271)
فهرسة مساهمة: Keywords: cytokines; diabetes; leprosy; neuropathic pain; neuropathy; nociceptive pain
المشرفين على المادة: 0 (Biomarkers)
0 (IL1B protein, human)
0 (IL6 protein, human)
0 (Interleukin-1beta)
0 (Interleukin-6)
تواريخ الأحداث: Date Created: 20200211 Date Completed: 20210223 Latest Revision: 20240325
رمز التحديث: 20240325
مُعرف محوري في PubMed: PMC6992577
DOI: 10.3389/fimmu.2020.00023
PMID: 32038662
قاعدة البيانات: MEDLINE